Early Phase Study of KESONOTIDE™in Participants With Solid Tumours

Clinical trial NCT06926075 · RECRUITING

Trial details

NCT number: NCT06926075
Sponsor: Filamon LTD
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancers Breast Cancer Lung Cancers Ovarian Cancer Glioblastoma Multiforme (GBM)Pancreas Cancer Skin Cancer

Start date: 2025-11-07
Primary completion: 2027-10-26
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.